Blog Post by Admin
Press Release
Apr 12, 2021
ICER to use Aetion observational RWE to update value assessment of treatments for hereditary angioedema
New ICER pilot will incorporate more than 24 months of observational real-world ...
Start Reading
News
Feb 24, 2021
Coronavirus infection leads to immunity that’s comparable to a COVID-19 vaccine
One of the enduring questions of the COVID-19 pandemic is how much immunity people are ...
Start Reading
News
Feb 24, 2021
COVID-19 antibodies may protect against reinfection later, study suggests
A study published in the journal JAMA Internal Medicine found that people who tested ...
Start Reading
News
Jan 11, 2021
Aetion: Fierce 15 Awards 2021
Amidst unprecedented challenges, adaptability emerged as a key determinant of success for ...
Start Reading
News
Dec 21, 2020
SARS-CoV-2 antibodies can protect from reinfection, NCI study suggests
As COVID-19 vaccines start to roll out in the US, research led by the National Cancer ...
Start Reading
Press Release
Dec 17, 2020
First RCT-DUPLICATE findings published in Circulation
NEW YORK, December 17, 2020 — Real-world evidence (RWE) studies can offer comparable ...
Start Reading
News
Dec 9, 2020
Her Story podcast: Fitting the pieces together with Carolyn Magill
This podcast episode features an interview with Carolyn Magill, the CEO of Aetion, a ...
Start Reading
News
Dec 8, 2020
‘Unpredictable pathogen’: New coronavirus study highlights severity of illness
While COVID-19 is commonly associated with symptoms like a loss of smell or taste, a new ...
Start Reading
Press Release
Oct 15, 2020
Aetion statement on UCSF-led study to inform drug development for COVID-19, future pandemics
NEW YORK, October 15, 2020 — Aetion co-authored a study published today in Science, which ...
Start Reading
News
Oct 8, 2020
Health analytics startup expands partnership with global pharma firm
As president and chief operating officer of Mount Sinai Hospital, Dr. David Reich ...
Start Reading
Press Release
Oct 7, 2020
UCB and Aetion announce agreement to enhance real-world evidence generation to advance value-based contracts
NEW YORK, Oct. 7, 2020 /PRNewswire/ -- Today, Aetion and UCB announced a new agreement to ...
Start Reading
News
Sep 18, 2020
Data-driven approach to COVID-19 requires rigor, transparency
Aetion CEO Carolyn Magill spoke with S&P Global Market Intelligence about the ...
Start Reading
News
Sep 16, 2020
MedCity Pivot: Real-world evidence with Carolyn Magill
Arundhati Parmar interviewed Carolyn Magill, CEO of Aetion. They discussed the growing ...
Start Reading
News
Sep 7, 2020
Ask the Experts: applications of real-world data during—and beyond—COVID-19
In this ‘Ask the Experts’ feature, explore some of the potential applications of ...
Start Reading
News
Sep 2, 2020
Aetion adds another $19M to its Series B to make sense of drug development and treatment data
AlleyWatch caught up with CEO Carolyn Magill to learn more about how the company powers ...
Start Reading
News
Aug 26, 2020
Aetion pushes Series B to $82M as pandemic puts real-world evidence under the spotlight
Former FDA chief Scott Gottlieb’s favorite real-world evidence platform is getting a new ...
Start Reading
Press Release
Aug 26, 2020
Aetion adds strategic investment from Johnson & Johnson Innovation — JJDC, Inc., EDBI, Greenspring Associates to expand RWE offerings
NEW YORK, August 26, 2020 — Today, Aetion, a health care technology company that delivers ...
Start Reading
News
Jul 20, 2020
Aetion, Cegedim Health Data partner on European RWE effort
Outsourcing Pharma writes in July 2020, Aetion and Cegedim Health Data announce plans to ...
Start Reading
News
Jul 9, 2020
Aetion, Cegedim form transatlantic real-world data alliance
Health tech companies Aetion and Cegedim have agreed to combine their data platforms, to ...
Start Reading
Press Release
Jul 8, 2020
Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europe
July 8, 2020 — Today Aetion and Cegedim Health Data announced a new partnership to ...
Start Reading
News
May 22, 2020
The Cures Act’s second act: Six ways to ensure Congress doubles down on its boldest bet
When the 21st Century Cures Act became law in 2016, the legislation boldly funded the ...
Start Reading
News
May 22, 2020
Real-world data partnership on COVID-19: US FDA drawn to consistency, diversity of Aetion's datasets
FDA's Amy Abernethy tells the Pink Sheet that initial priorities are likely to include ...
Start Reading
News
May 20, 2020
FDA partners with Aetion to gather real-world data on the coronavirus
The Food and Drug Administration has invested in real-world data for several years, ...
Start Reading
News
May 20, 2020
FDA, Aetion partner on real-world data analytics for COVID-19
EndpointsNews writes in 2020 that the FDA will partner with New York-based health ...
Start Reading